1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia Masvidal; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine A.; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy A.;... Journal: Journal for immunotherapy of cancer Issue: Volume 4(2016)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. An open-label, multicohort Phase Ib trial of pembrolizumab (MK-3475) for advanced hematologic malignancies: KEYNOTE-013. Issue 2 (December 2015) Authors: Ribrag, Vincent; Armand, Phillippe; Kuruvilla, John; Michot, Jean-Marie; Moskowitz, Craig; Marinello, Patricia; Snyder, Ellen; Balakumaran, Arun; Shipp, Margaret; Zinzani, Pier Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Bendamustine in combination with ofatumumab as first line treatment for elderly patients with mantle cell lymphoma: a phase II risk-adapted design. Issue 12 (15th October 2022) Authors: Kumar, Anita; Casulo, Carla; Joffe, Erel; Moskowitz, Craig; Gerecitano, John; Moskowitz, Alison; Younes, Anas; Drullinsky, Pamela; Drill, Esther; Choma, Morgan; Grieve, Clare; Joseph, Ashlee; Laraque, Leana; Schick, Dylan; Zelenetz, Andrew; Hamlin, Paul Journal: Leukemia & lymphoma Issue: Volume 63:Issue 12(2022) Page Start: 2889 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Central nervous system involvement in T-cell lymphoma: A single center experience. (3rd May 2016) Authors: Gurion, Ronit; Mehta, Neha; Migliacci, Jocelyn C; Zelenetz, Andrew; Moskowitz, Alison; Lunning, Matthew; Moskowitz, Craig; Hamlin, Paul; Horwitz, Steven Journal: Acta oncologica Issue: Volume 55:Number 5(2016) Page Start: 561 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas. Issue 16 (November 2015) Authors: Gounder, Mrinal; Desai, Ved; Kuk, Deborah; Agaram, Narasimhan; Arcila, Maria; Durham, Benjamin; Keohan, Mary L.; Dickson, Mark A.; D'Angelo, Sandra P.; Shukla, Neerav; Moskowitz, Craig; Noy, Ariela; Maki, Robert G.; Herrera, Diego Adrianzen; Sanchez, Armando; Krishnan, Anita; Pourmoussa, Andrew; ... Journal: European journal of cancer Issue: Volume 51:Issue 16(2015:Nov.) Page Start: 2413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Patient-reported outcomes in KEYNOTE-087, a phase 2 study of pembrolizumab in patients with classical Hodgkin lymphoma. Issue 11 (19th September 2019) Authors: von Tresckow, Bastian; Fanale, Michelle; Ardeshna, Kirit M.; Chen, Robert; Meissner, Julia; Morschhauser, Franck; Moskowitz, Craig; Zinzani, Pier Luigi; Giezek, Hilde; Balakumaran, Arun; Vo, Thao T.; Raut, Monika; Brice, Pauline Journal: Leukemia & lymphoma Issue: Volume 60:Issue 11(2019) Page Start: 2705 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Phase II study of pembrolizumab (MK-3475) for relapsed/refractory classical Hodgkin Lymphoma (r/r cHL): keynote-087. Issue 2 (December 2015) Authors: Chen, Robert; Armand, Phillippe; Fanale, Michelle; Ribrag, Vincent; Zinzani, Pier; Ricart, Alejandro; Thompson, Seth; Balakumaran, Arun; Molin, Daniel; Shipp, Margaret; Moskowitz, Craig Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗